XIPERE
Live / Registered — Registered (as of 15 Mar 2022)
What this means for you
Registered since 15 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87896124
- Registration number
- 6672372
- Mark type
- Stylized text
- Filed
- 27 Apr 2018
- Published for opposition
- 25 Sept 2018
- Registered
- 15 Mar 2022
- Attorney of record
- Bassam N. Ibrahim
Goods and services
- Class 005 — Pharmaceuticals: Ocular pharmaceuticals; ophthalmic preparations
- Class 010 — Medical apparatus: Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
Owner
- Clearside Biomedical, Inc., Alpharetta, GA, US
- Clearside Biomedical, Inc., Alpharetta, GA, US
- Clearside Biomedical, Inc., Alpharetta, GA, US
Prosecution history
- 03 Sept 2022 — REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
- 03 Sept 2022 — CORRECTION UNDER SECTION 7 - PROCESSED
- 31 Aug 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Apr 2022 — TEAS SECTION 7 REQUEST RECEIVED
- 15 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 09 Feb 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Feb 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Jan 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jan 2022 — USE AMENDMENT FILED
- 06 Jan 2022 — TEAS STATEMENT OF USE RECEIVED
- 17 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2021 — SOU EXTENSION 5 GRANTED
- 07 Sept 2021 — SOU EXTENSION 5 FILED
- 14 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Sept 2021 — SOU TEAS EXTENSION RECEIVED